Purchase Order 75N98026P00733
Award Date 6/17/26
Potential Completion Date 8/12/26
Potential Value $51K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $160,371.00 on May 31, 2026, for firm fixed-price procurement of genetic sequencing equipment, reagents, or related consumables. No set-aside was used. Work is performed in San Diego, California. The order is scheduled for completion by May 30, 2027.</p>
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $48,209 firm fixed price purchase order to Illumina, Inc. for a service contract to provide a NextSeq 2000 DNA sequencer with serial number VH01190. The single-year contract, valued at forty-eight thousand two hundred nine US dollars, will be performed at the NIH Clinical Center campus located in Bethesda, Maryland through September 2024. Illumina will deliver the requested DNA sequencing...
- The National Institutes of Health Clinical Center awarded a $279,999.93 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide two NextSeq 1000 Sequencing Systems to replace older equipment. The solicitation sought sequencing systems that could automatically generate DNA clusters and perform sequencing, primary, and secondary analysis compatible with existing assays, reagents, consumables, software, and workflows. As the only vendor...
- <p>The NIH Clinical Center issued a $20,765.16 delivery order to Illumina, Inc. on August 14, 2019, for genetic sequencing equipment and related technologies.</p> <p>Place of performance is San Diego, CA 92122. The order was firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- <p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $96,921.00 on March 11, 2020, for firm fixed-price delivery of genetic sequencing equipment and reagents. No small business set-aside applied. The order was placed against a pre-solicitation opportunity posted February 14, 2020 with a proposal due date of February 24, 2020. Performance is located at Bethesda, Maryland. The purchase order has an ultimate completion date of April 28, 2021.</p>
- <p>The National Institutes of Health Clinical Center issued a delivery order to Illumina, Inc. on June 20, 2019, with a ceiling value of $11,878.92 for genomic sequencing equipment or reagents.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- The NIH Clinical Center awarded a purchase order valued at $256,576.92 to Illumina, Inc. for two MiSeq Sequencing Systems (serial numbers M07700 and M08636) on December 12, 2024. This firm fixed-price contract carries an ultimate completion date of December 11, 2029 and utilizes no set-aside designation. Illumina, a leading biotechnology company headquartered in San Diego, California, specializes in genetic sequencing and genomic analysis technologies. The MiSeq platform represents a...
- <p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $52,345.49 on December 6, 2018, for genetic sequencing and genomic analysis technologies. Performance took place in Bethesda, Maryland, with ultimate completion by May 5, 2019. The purchase order was issued on a firm fixed-price basis without a set-aside designation, following a pre-solicitation opportunity posted November 20, 2018, with a due date of November 30, 2018.</p>
- <p>The National Institutes of Health National Human Genome Research Institute (NIH NHGRI) awarded a $999,999 firm fixed price purchase order to Illumina, Inc. of San Diego, California for a NOVASEQ X PLUS SEQUENCING SYSTEM. The sequencing system will be delivered to the prime contractor's location in San Diego between June 22, 2023 and September 29, 2023 to support the NIH NHGRI's genomic research efforts.</p>
- <p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $19,331.05 on July 5, 2016, with an ultimate completion date of August 17, 2016. No set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price. Specific details regarding the nature of the equipment or consumables procured are not provided in the source material.</p>
The NIH Clinical Center awarded a purchase order to Illumina, Inc. for a benchtop next-generation sequencer valued at $50,521.88 on June 17, 2026, with an ultimate completion date of August 12, 2026. Performance occurs in San Diego, California. The order is firm fixed price with no set-aside designation. This procurement supplies laboratory equipment for genetic sequencing capabilities supporting NIH research and diagnostic operations.
Generated 6/17/26, 11:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.5k | 6/15/26 |